Xiaolin Wang - Jun 17, 2022 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
EVP, Clinical Development
Signature
/s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang
Stock symbol
RVMD
Transactions as of
Jun 17, 2022
Transactions value $
-$11,803
Form type
4
Date filed
6/22/2022, 05:03 PM
Previous filing
Mar 21, 2022
Next filing
Sep 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Sale -$11.8K -665 -2.04% $17.75 32K Jun 17, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
F2 Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022.
F3 Includes 26,450 RSUs.

Remarks:

EVP, Clinical Development